BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 229712)

  • 1. Relationship of human urinary and plasma kinins to sodium-retaining steroids and plasma renin activity.
    Vinci JM; Zusman RM; Izzo JL; Bowden RE; Horwitz D; Pisano JJ; Keiser HR
    Adv Exp Med Biol; 1979; 120B():503-14. PubMed ID: 229712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human urinary and plasma kinins: relationship to sodium-retaining steroids and plasma renin activity.
    Vinci JM; Zusman RM; Izzo JL; Bowden RE; Horwitz D; Pisano JJ; Keiser HR
    Circ Res; 1979 Feb; 44(2):228-37. PubMed ID: 216504
    [No Abstract]   [Full Text] [Related]  

  • 4. The kallikrein-kinin system in essential hypertension.
    Keiser HR
    Clin Exp Hypertens (1978); 1980; 2(3-4):675-91. PubMed ID: 7000465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostaglandins, kallikrein-kinin and dopamine. Practical implications of this vasodilator-natriuretic system].
    Abenhaim L; Kuchel O
    Union Med Can; 1979 Jun; 108(6):621-39. PubMed ID: 388782
    [No Abstract]   [Full Text] [Related]  

  • 7. Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
    Tamura Y; Matsuda Y; Yamada K; Takagi T; Nishikawa T; Watanabe M; Mikami K; Moriya H; Kumagai A
    Adv Exp Med Biol; 1979; 120B():515-24. PubMed ID: 517245
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary kallikrein excretion in Bartter's syndrome.
    Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225).
    Matthews PG; Johnston CI
    Adv Exp Med Biol; 1979; 120B():447-57. PubMed ID: 390990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
    Wong PY; Talamo RC; Williams GH; Colman RW
    J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 12. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.
    Abe K; Sato M; Kasai Y; Haruyama T; Sato K; Miyazaki S; Imai Y; Hiwatari M; Itoh T; Sakurai Y; Goto T; Tajima J; Seino M; Yoshinaga K
    Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium restriction and angiotensin II infusion in Bartter's syndrome.
    Sann L; David M; Richard P; Floret D; Sassard J; Bizollon CA; Francois R
    Pediatr Res; 1976 Dec; 10(12):971-7. PubMed ID: 995500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinins in blood and urine with special reference to intrarenal kinin formation in normal and hypertensive individuals.
    Hulthén L
    Acta Endocrinol Suppl (Copenh); 1980; 235():1-63. PubMed ID: 6250313
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of renin, kinins and prostaglandins.
    Cinotti GA
    J Hypertens Suppl; 1983 Oct; 1(1):43-51. PubMed ID: 6400108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating plasma prekallikrein and tissue kallikrein in normotensive and hypertensive humans: effects of angiotensin II infusion.
    Ohman KP; Karlberg BE
    Clin Exp Hypertens; 1998 Apr; 20(3):313-28. PubMed ID: 9605385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.